4
MARKET OVERVIEW
Captures industry movement, adoption patterns, and strategic signals across key end-use segments and regions.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
Market Size, Volume & Forecast – USD Million
5
INDUSTRY TRENDS
Outlines emerging trends, technology impact, and regulatory signals affecting growth trajectory and stakeholder decisions.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN PACKAGING TYPE
5.2.4
TRENDS IN DRUG DELIVERY SYSTEMS
5.1.1
AVERAGE SELLING PRICE TREND OF TYPE, BY KEY PLAYERS (2022–2025)
5.1.2
AVERAGE SELLING PRICE TREND, BY COUNTRY (2022–2025)
5.1.1
IMPORT SCENARIO (HS CODE: 392390)
5.1.2
EXPORT SCENARIO (HS CODE: 392390)
5.6
KEY CONFERENCES AND EVENTS, 2026–2027
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.8
INVESTMENT AND FUNDING SCENARIO
5.10
IMPACT OF 2025 US TARIFF – EUROPE PHARMACEUTICAL PACKAGING MARKET
5.10.3
PRICE IMPACT ANALYSIS
5.10.4
IMPACT ON COUNTRIES
5.10.5
IMPACT ON APPLICATIONS
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1.1.1
BLISTER PACKAGING TECHNOLOGY
6.1.1.2
PARENTERAL PACKAGING SYSTEMS
6.1.2
COMPLEMENTARY TECHNOLOGIES
6.1.2.1
SMART & CONNECTED PACKAGING
6.1.2.2
COLD CHAIN PACKAGING
6.1.3
ADJACENT TECHNOLOGIES
6.1.3.1
DIGITAL HEALTH & IOT INTEGRATION
6.1.3.2
3D PRINTING OF PACKAGING COMPONENTS
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.7
IMPACT OF AI/GEN AI ON EUROPE PHARMACEUTICAL PACKAGING MARKET
6.6.1
TOP USE CASES AND MARKET POTENTIAL
6.6.2
BEST PRACTICES BY EUROPEAN MANUFACTURERS IN PHARMACEUTICAL PACKAGING
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN EUROPE PHARMACEUTICAL PACKAGING MARKET
6.6.4
INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.6.5
CLIENTS’ READINESS TO ADOPT AI IN EUROPE PHARMACEUTICAL PACKAGING MARKET
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY INITIATIVES
7.3
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.2
DECISION-MAKING PROCESS
8.3
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
8.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.4
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.5
UNMET NEEDS FROM VARIOUS APPLICATIONS
7
EUROPE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION & VOLUME, KILOTON)
7.1.1
HIGH-DENSITY POLYETHYLENE
7.1.4
LOW-DENSITY POLYETHYLENE
7.1.6
CYCLIC OLEFIN COPOLYMER
7.1.7
POLYETHYLENE TEREPHTHALATE
8
EUROPE PHARMACEUTICAL PACKAGING MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION & VOLUME, KILOTON)
8.1.1
STANDARD PLASTIC BOTTLES
8.1.2
PLASTIC DISPENSING BOTTLES
8.5
MEDICAL SPECIALTY BAGS
8.7
TEMPERATURE-CONTROLLED PACKAGING
8.8
POUCHES & STRIP PACKS
8.1.11
METERED DOSE INHALERS
8.1.12
DRY POWDER INHALERS
8.1.15
COLLAPSIBLE METAL TUBES
9
EUROPE PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION & VOLUME, KILOTON)
10
EUROPE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION & VOLUME, KILOTON)
11
EUROPE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY
Market Size, Volume & Forecast – USD Million
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
12.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN (2021–2025)
12.3
REVENUE ANALYSIS (2022–2024)
12.4
MARKET SHARE ANALYSIS (2024)
12.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
12.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
12.6.5.1
COMPANY FOOTPRINT
12.6.5.2
COUNTRY FOOTPRINT
12.6.5.4
DRUG DELIVERY FOOTPRINT
12.6.5.5
PACKAGING TYPE FOOTPRINT
12.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
12.7.1
PROGRESSIVE COMPANIES
12.7.2
RESPONSIVE COMPANIES
12.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
12.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
12.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
12.8
COMPANY VALUATION AND FINANCIAL METRICS
12.9
COMPETITIVE SCENARIO
13.1.1.1
BUSINESS OVERVIEW
13.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
13.1.1.3.1
KEY STRENGTHS/RIGHT TO WIN
13.1.1.3.2
STRATEGIC CHOICES
13.1.1.3.3
WEAKNESSES/COMPETITIVE THREATS
13.1.6
ORIGIN PHARMA PACKAGING
14.1.1.1
KEY DATA FROM SECONDARY SOURCES
14.1.1.2
LIST OF KEY SECONDARY SOURCES
14.1.2.1
KEY DATA FROM PRIMARY SOURCES
14.1.2.2
KEY PRIMARY PARTICIPANTS
14.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
14.1.2.4
KEY INDUSTRY INSIGHTS
14.2
MARKET SIZE ESTIMATION
14.2.1
BOTTOM-UP APPROACH
14.2.3
MARKET SIZE CALCULATION FOR BASE YEAR
14.3
MARKET FORECAST APPROACH
14.6
RESEARCH ASSUMPTIONS AND LIMITATIONS
15.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3
CUSTOMIZATION OPTIONS
Growth opportunities and latent adjacency in Europe Pharmaceutical Packaging Market